Support research work in Cambridge to repair myelin and preserve function in multiple sclerosis (MS)
Dr Nick Cunniffe leads the Cambridge Clinical Remyelination Research Group, a team dedicated to developing treatments that can reverse damage in MS.
MS is a lifelong neurological condition affecting over 150,000 people in the UK, causing disability through the loss of myelin - the protective sheath around nerve fibres. This damage disrupts communication within the brain and spinal cord, leading to physical, cognitive, and visual impairments.
The group’s research focuses on remyelination: repairing this damaged myelin to restore nerve function and prevent or reverse disability. In Cambridge, the team is running innovative clinical trials to test promising drugs that enhance the brain’s natural repair processes. They are also developing advanced imaging and blood-based tests to measure remyelination more precisely and efficiently. These approaches will help identify which treatments work, for whom, and at what time.
Supporting this research will accelerate the development of therapies that could delay, prevent, or reverse disability associated with multiple sclerosis.
Next steps
You can support this research by giving a gift online now or to discuss your philanthropic objectives, please contact:
Make a gift now
Make a gift now to support SCM(Clinical Neurosciences) - N Cunniffe Research Group by credit or debit card, or set up a direct debit:
Or, find out about other ways to give.
Display none
This opportunity is part of
Related stories
Philanthropic giving is at the heart of the success of the Collegiate University, enabling us to make discoveries that change the world and to ensure that our students receive an unrivalled education. Cambridge owes its world-leading excellence in research and teaching to the generosity of its supporters. Our history is synonymous with a history of far-sighted benefaction, and the same is as true today as it has ever been.
